Key statistics dashboard for Aclarion, Inc. (ACON). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications.
Stock Data
| Price | $2.55 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.34 |
| Price / Book | 0.37 |
| P/S | 16.23 |
| P/FCF | -0.17 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -50.96% |
| EBIT Margin | -10978.48% |
| EBITDA Margin | -10689.05% |
| Operating Margin | -11592.14% |
| Net Margin | -10978.48% |
Financial Health
| Current Ratio | 16.20 |
| Quick Ratio | 16.20 |
| Cash Ratio | 15.71 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -4.92 |
Per-Share Data
| Revenue per share | 0.03 |
| Book Value per share | 6.91 |
| Cash per share | 6.61 |
| FCF per share | -3.28 |
| Tangible Book Value per share | 6.41 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 0.50 |